Wang Shan, Yin Haiyan. Advances in exosomes derived from the mesenchymal stem cells in the treatment of sepsis[J]. Chin j Burns, 2019, 35(1): 77-80. Doi: 10.3760/cma.j.issn.1009-2587.2019.01.016
Citation: Wang Shan, Yin Haiyan. Advances in exosomes derived from the mesenchymal stem cells in the treatment of sepsis[J]. Chin j Burns, 2019, 35(1): 77-80. Doi: 10.3760/cma.j.issn.1009-2587.2019.01.016

Advances in exosomes derived from the mesenchymal stem cells in the treatment of sepsis

doi: 10.3760/cma.j.issn.1009-2587.2019.01.016
  • Received Date: 2017-11-24
    Available Online: 2021-10-28
  • Publish Date: 2019-01-20
  • Exosomes derived from mesenchymal stem cells (MSCs) are small membrane vesicles with diameters in 30-150 nm, which are secreted into extracellular matrix by MSCs in resting or activated state. Recent studies have found that exosomes secreted by MSCs can be used as important signal transduction mediator, which can transport bioactive substances such as mRNA, microRNA, and proteins effectively to target cells, and play important roles in regulating tissue regeneration and immunomodulation. Here we give an overview of biological properties, mechanisms, and the roles in treating sepsis of exosome derived from MSCs, in order to provide some basises to highlight the MSCs-exosomes therapy in sepsis.

     

  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (134) PDF downloads(12) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return